NYSE$DNMRQ

Danimer Scientific Inc. · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Briefing

Announced second quarter 2023 results, expanded portfolio with resins for protective films, shrink wrap & produce bags, and had Part 2 Application accepted for DoE Loan Guarantee.

Danimer Scientific's second quarter 2023 revenues grew to $12.9 million compared to $12.7 million in the year-ago quarter. The company's net loss for the quarter was $(39.2) million, compared to $(30.4) million in the prior year period.

  • Revenues grew to $12.9 million in the second quarter of 2023, compared to $12.7 million in the year-ago quarter.
  • Product revenue was $12.2 million, driven by stronger sales of PHA-based resins, which increased 10% compared to prior year and 69% sequentially.
  • Net loss for the second quarter was $(39.2) million compared with $(30.4) million in the prior year period.
  • Adjusted EBITDA in the second quarter of 2023 improved to $(10.2) million as compared to $(12.9) million in the second quarter of 2022.

Headline financials

Total Revenue

$12.9M

Previous: $12.7M+1.3%
EPS (adj)

-$0.38

Previous: -$0.30-26.7%
Capital Expenditures

$6.64M

Previous: $49.9M-86.7%
Free Cash Flow

-$21.9M

Previous: -$69.7M+68.6%
Net Income

-$39.2M

Previous: -$30.4M-28.9%
Operating Income

-$31.1M

Previous: -$32.1M+3.1%
Gross Profit

-$6.57M

Previous: -$2.2M-198.5%
Cash & Equivalents

$90.8M

Previous: $140M-35.3%
Total Assets

$744M

Previous: $791M-5.9%
Stock-Based Comp

$13.9M

Previous: $14.2M-2.3%

Revenue & EPS history

Danimer Scientific · Revenue · Quarterly

$12.9M

Q2 2023+1.3%vs Q2 2022
Beat estimate in 3 of 15 quarters(20%)
ActualEstimate

Revenue by segment

Danimer Scientific · $12.9M total across 2 segments · Q2 2023

  • Products
    $12.2M+5.2%
  • Services
    $691K-38.7%

Forward guidance

The Company now believes that a bias toward the low end of its previously communicated range for 2023 full-year Adjusted EBITDA of $(23) million to $(31) million is prudent. The Company continues to anticipate full-year capital expenditures in the range of $26 million to $31 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 11 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

+1.1%

Avg return

Earnings day

+2.4%

Avg return

5 days after

-19.1%

Avg return

30 days after

58%

11 / 19 earnings

Positive

+26.3%

Q1 2023

Best reaction

-29.0%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2024+0.0%+0.0%+0.0%
Q3 2024-29.0%-36.3%-69.3%
Q2 2024-0.9%-7.1%-27.9%
Q1 2024-3.7%-1.9%-28.2%
Q4 2023+2.0%-10.7%-38.0%
Q3 2023+2.0%-2.8%-16.7%
Q2 2023-6.4%-14.2%-24.4%
Q1 2023+26.3%+27.0%+3.1%
Q4 2022+9.3%+28.2%+17.1%
Q3 2022+3.7%+23.2%-14.9%
Q2 2022+4.3%+21.3%-11.2%
Q1 2022-3.6%
Q4 2021+21.1%
Q3 2021-18.0%
Q2 2021-2.9%
Q1 2021+12.0%
Q4 2020+2.5%
Q2 2020+2.5%
Q3 2020+0.3%
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro